The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.

By Brent E. Wisse. Journal of the American Society of Nephrology, 2004

1,017 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology

View Paper: https://www.semanticscholar.org/paper/447901cf2d785243e1fadd59e5b725e18eabfb40

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. M. Kurella
2. J. Lo
3. Glenn M. Chertow

Citations in the corpus

• Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. (2005, background): “Others have speculated a direct role for insulin resistance and hyperinsulinemia (35), inflammation resulting from lipotoxicity (36,37), reduced nephron number, and increased excretory load (38,39).”
• Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. (2006, background): “While several studies have supported a role for increased TNF signaling in obesity [20] and NAFLD [7,10,21], fewer have examined the role of other inflammatory mediators in this disorder.”
• A global perspective on carotenoids: Metabolism, biotechnology, and benefits for nutrition and health. (2018, background): “Adipose tissue oxidative stress and inflammation are thought to play a major role in the onset of insulin resistance [427, 428].”